JP2000508665A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000508665A5 JP2000508665A5 JP1997537622A JP53762297A JP2000508665A5 JP 2000508665 A5 JP2000508665 A5 JP 2000508665A5 JP 1997537622 A JP1997537622 A JP 1997537622A JP 53762297 A JP53762297 A JP 53762297A JP 2000508665 A5 JP2000508665 A5 JP 2000508665A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK49096 | 1996-04-24 | ||
| DK0490/96 | 1996-04-24 | ||
| PCT/DK1997/000184 WO1997039768A1 (en) | 1996-04-24 | 1997-04-24 | A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008145780A Division JP2008231124A (ja) | 1996-04-24 | 2008-06-03 | 成長ホルモン、アミノ酸及び非イオン洗浄剤を含有する医薬配合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2000508665A JP2000508665A (ja) | 2000-07-11 |
| JP2000508665A5 true JP2000508665A5 (enExample) | 2005-01-13 |
| JP4176834B2 JP4176834B2 (ja) | 2008-11-05 |
Family
ID=8094154
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP53762297A Expired - Lifetime JP4176834B2 (ja) | 1996-04-24 | 1997-04-24 | 成長ホルモン、アミノ酸及び非イオン洗浄剤を含有する医薬配合物 |
| JP2008145780A Withdrawn JP2008231124A (ja) | 1996-04-24 | 2008-06-03 | 成長ホルモン、アミノ酸及び非イオン洗浄剤を含有する医薬配合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008145780A Withdrawn JP2008231124A (ja) | 1996-04-24 | 2008-06-03 | 成長ホルモン、アミノ酸及び非イオン洗浄剤を含有する医薬配合物 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20020077461A1 (enExample) |
| EP (2) | EP1629832A1 (enExample) |
| JP (2) | JP4176834B2 (enExample) |
| KR (1) | KR20000010630A (enExample) |
| CN (1) | CN1130223C (enExample) |
| AT (1) | ATE309819T1 (enExample) |
| AU (1) | AU733592B2 (enExample) |
| BR (1) | BR9708858A (enExample) |
| CA (1) | CA2252535C (enExample) |
| CZ (1) | CZ298292B6 (enExample) |
| DE (1) | DE69734653T2 (enExample) |
| DK (1) | DK0904099T3 (enExample) |
| ES (1) | ES2253774T3 (enExample) |
| HU (1) | HU229868B1 (enExample) |
| IL (2) | IL126463A0 (enExample) |
| NO (1) | NO323360B1 (enExample) |
| PL (1) | PL188222B1 (enExample) |
| RU (1) | RU2236250C2 (enExample) |
| UA (1) | UA66758C2 (enExample) |
| WO (1) | WO1997039768A1 (enExample) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5981485A (en) * | 1997-07-14 | 1999-11-09 | Genentech, Inc. | Human growth hormone aqueous formulation |
| KR100491282B1 (ko) | 1996-07-24 | 2005-05-24 | 워너-램버트 캄파니 엘엘씨 | 통증 치료용 이소부틸가바 및 그의 유도체 |
| AU1375199A (en) * | 1997-11-12 | 1999-05-31 | Alza Corporation | Method for decreasing self-association of polypeptides |
| GB9803448D0 (en) * | 1998-02-18 | 1998-04-15 | Pharma Mar Sa | Pharmaceutical formulation |
| JP4711520B2 (ja) * | 2000-03-21 | 2011-06-29 | 日本ケミカルリサーチ株式会社 | 生理活性ペプチド含有粉末 |
| MXPA03001092A (es) | 2000-08-07 | 2003-09-25 | Nektar Therapeutics Al Corp | Polvos de proteina de haz de 4 helices secados por rocio, inhalables, que tienen agregacion minimizada. |
| EP1603588A2 (en) * | 2003-03-18 | 2005-12-14 | Ares Trading S.A. | Stabilisation of growth hormones in solution |
| EP1605922A4 (en) * | 2003-03-24 | 2011-03-16 | Biosphere Medical Inc | TEMPORARY EMBOLIZATION USING REVERSIBLE THERMOSENSIVE POLYMERS WITH MOMENTARY ACTION |
| DE10333317A1 (de) * | 2003-07-22 | 2005-02-17 | Biotecon Therapeutics Gmbh | Formulierung für Proteinarzneimittel ohne Zusatz von humanem Serumalbumin (HSA) |
| US7700086B2 (en) * | 2003-11-06 | 2010-04-20 | Pluromed, Inc. | Internal clamp for surgical procedures |
| BRPI0418115A (pt) * | 2003-12-23 | 2007-04-17 | Pharmacia Corp | formulação lìquida estável de hormÈnio de crescimento |
| CN100574801C (zh) * | 2004-04-07 | 2009-12-30 | 阿雷斯贸易股份有限公司 | 液体生长激素制剂 |
| ZA200704926B (en) * | 2004-12-22 | 2008-12-31 | Ambrx Inc | Modified human growth hormone |
| BRPI0519170A8 (pt) * | 2004-12-22 | 2018-05-08 | Ambrx Inc | formulações de hormônio de crescimento humano que compreendem um aminoácido não naturalmente codificado |
| KR20070090023A (ko) * | 2004-12-22 | 2007-09-04 | 암브룩스, 인코포레이티드 | 변형 인간 성장 호르몬 |
| CA2620638A1 (en) | 2005-08-30 | 2007-03-08 | Novo Nordisk Health Care Ag | Liquid formulations of pegylated growth hormone |
| WO2007033427A1 (en) * | 2005-09-23 | 2007-03-29 | Metabolic Pharmaceuticals Limited | Stabilisation of peptides with basic amino acids |
| CN1939534B (zh) | 2005-09-27 | 2010-12-01 | 长春金赛药业股份有限公司 | 含有人生长激素或人粒细胞巨噬细胞刺激因子的用于治疗损伤和溃疡的外用制剂 |
| ES2605022T3 (es) | 2006-07-06 | 2017-03-10 | Daewoong Co., Ltd. | Una formulación líquida estable de la hormona del crecimiento humana |
| US9175061B2 (en) | 2006-07-07 | 2015-11-03 | Novo Nordisk Health Care Ag | Protein conjugates and methods for their preparation |
| WO2008076819A2 (en) * | 2006-12-18 | 2008-06-26 | Altus Pharmaceuticals Inc. | Human growth hormone formulations |
| AU2011208620B2 (en) | 2010-01-22 | 2015-04-16 | Novo Nordisk Health Care Ag | Stable growth hormone compounds |
| CN103002918B (zh) | 2010-01-22 | 2016-05-04 | 诺沃—诺迪斯克保健股份有限公司 | 体内功效延长的生长激素 |
| KR101337797B1 (ko) * | 2010-07-14 | 2013-12-06 | 한미사이언스 주식회사 | 지속형 인간 성장 호르몬 결합체 액상 제제 |
| AU2011306653B2 (en) * | 2010-09-21 | 2014-06-05 | Ferring B.V. | Improved process for production of recombinant human growth hormone |
| US9216219B2 (en) | 2012-06-12 | 2015-12-22 | Novartis Ag | Anti-BAFFR antibody formulation |
| US20150182490A1 (en) | 2012-06-26 | 2015-07-02 | Del Mar Pharmaceuticals | Methods for treating tyrosine-kinase-inhibitor-resistant malignancies in patients with genetic polymorphisms or ahi1 dysregulations or mutations employing dianhydrogalactitol, diacetyldianhydrogalactitol, dibromodulcitol, or analogs or derivatives thereof |
| EP2981282B1 (en) | 2013-04-05 | 2020-11-04 | Novo Nordisk Health Care AG | Growth hormone compound formulation |
| KR20160061911A (ko) | 2013-04-08 | 2016-06-01 | 데니스 엠. 브라운 | 최적하 투여된 화학 화합물의 치료 효과 |
| WO2015013579A1 (en) | 2013-07-26 | 2015-01-29 | Update Pharma Inc. | Compositions to improve the therapeutic benefit of bisantrene |
| HK1225976A1 (en) * | 2013-09-27 | 2017-09-22 | Hanmi Pharm. Co., Ltd. | Sustained type human growth hormone preparation |
| US9119832B2 (en) | 2014-02-05 | 2015-09-01 | The Regents Of The University Of California | Methods of treating mild brain injury |
| WO2017075535A1 (en) | 2015-10-28 | 2017-05-04 | Oxeia Biopharmaceuticals, Inc. | Methods of treating neurodegenerative conditions |
| HUE064656T2 (hu) | 2016-03-28 | 2024-04-28 | Incyte Corp | Pirrolotriazin vegyületek mint TAM inhibitorok |
| US11932699B2 (en) | 2017-09-07 | 2024-03-19 | Jcr Pharmaceuticals Co., Ltd. | Aqueous pharmaceutical composition |
| KR102739325B1 (ko) | 2017-09-27 | 2024-12-09 | 인사이트 코포레이션 | Tam 억제제로서 유용한 피롤로트리아진 유도체의 염 |
| ES3031110T3 (en) | 2018-06-29 | 2025-07-04 | Incyte Corp | Formulations of an axl/mer inhibitor |
| AU2021230385A1 (en) | 2020-03-06 | 2022-09-22 | Incyte Corporation | Combination therapy comprising AXL/MER and PD-1/PD-L1 inhibitors |
| CN115634284B (zh) * | 2022-10-31 | 2025-02-11 | 景泽生物医药(合肥)股份有限公司 | 一种促性腺激素冻干制剂及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994003198A1 (en) * | 1992-07-31 | 1994-02-17 | Genentech, Inc. | Human growth hormone aqueous formulation |
| US5096885A (en) * | 1988-04-15 | 1992-03-17 | Genentech, Inc. | Human growth hormone formulation |
| DK204791D0 (da) * | 1991-12-20 | 1991-12-20 | Novo Nordisk As | Hidtil ukendt farmaceutisk praeparat |
| DE10399015I1 (de) * | 1991-12-20 | 2012-05-03 | Novo Nordisk As | Stabilisierte pharmazeutische formulierung, die wachstumshormon und histidin enthält |
-
1997
- 1997-04-23 US US08/842,293 patent/US20020077461A1/en not_active Abandoned
- 1997-04-24 RU RU98121135/15A patent/RU2236250C2/ru active
- 1997-04-24 CA CA002252535A patent/CA2252535C/en not_active Expired - Lifetime
- 1997-04-24 DE DE69734653T patent/DE69734653T2/de not_active Expired - Lifetime
- 1997-04-24 AT AT97918073T patent/ATE309819T1/de active
- 1997-04-24 HU HU9902476A patent/HU229868B1/hu unknown
- 1997-04-24 EP EP05110701A patent/EP1629832A1/en not_active Withdrawn
- 1997-04-24 CZ CZ0320798A patent/CZ298292B6/cs not_active IP Right Cessation
- 1997-04-24 AU AU26343/97A patent/AU733592B2/en not_active Expired
- 1997-04-24 PL PL97329386A patent/PL188222B1/pl unknown
- 1997-04-24 WO PCT/DK1997/000184 patent/WO1997039768A1/en not_active Ceased
- 1997-04-24 KR KR1019980708535A patent/KR20000010630A/ko not_active Ceased
- 1997-04-24 UA UA98105593A patent/UA66758C2/xx unknown
- 1997-04-24 EP EP97918073A patent/EP0904099B1/en not_active Expired - Lifetime
- 1997-04-24 JP JP53762297A patent/JP4176834B2/ja not_active Expired - Lifetime
- 1997-04-24 ES ES97918073T patent/ES2253774T3/es not_active Expired - Lifetime
- 1997-04-24 CN CN97194040A patent/CN1130223C/zh not_active Expired - Lifetime
- 1997-04-24 IL IL12646397A patent/IL126463A0/xx active IP Right Grant
- 1997-04-24 BR BR9708858A patent/BR9708858A/pt not_active Application Discontinuation
- 1997-04-24 DK DK97918073T patent/DK0904099T3/da active
-
1998
- 1998-10-04 IL IL126463A patent/IL126463A/en not_active IP Right Cessation
- 1998-10-23 NO NO19984951A patent/NO323360B1/no not_active IP Right Cessation
-
2008
- 2008-06-03 JP JP2008145780A patent/JP2008231124A/ja not_active Withdrawn